Table 3.

Multivariable Models Assessing the Association of Untreated and Treated Hepatitis C With Active Tuberculosis

HCV CategoryaHR (95% CI)a
Main Model Without IPWMain Model With IPWSensitivity Analysis 1Sensitivity Analysis 2Sensitivity Analysis 3
Untreated HCV infection2.9 (2.4, 3.4)2.9 (2.4, 3.4)2.9 (2.5, 3.4)2.9 (2.4, 3.4)3.0 (2.5, 3.6)
Treated HCV infection1.7 (1.4, 2.0)1.6 (1.4, 2.0)1.7 (1.4, 2.1)1.6 (1.4, 2.0)1.5 (1.2, 1.8)
Never infected with HCV11111
HCV CategoryaHR (95% CI)a
Main Model Without IPWMain Model With IPWSensitivity Analysis 1Sensitivity Analysis 2Sensitivity Analysis 3
Untreated HCV infection2.9 (2.4, 3.4)2.9 (2.4, 3.4)2.9 (2.5, 3.4)2.9 (2.4, 3.4)3.0 (2.5, 3.6)
Treated HCV infection1.7 (1.4, 2.0)1.6 (1.4, 2.0)1.7 (1.4, 2.1)1.6 (1.4, 2.0)1.5 (1.2, 1.8)
Never infected with HCV11111

Adults tested for HCV antibodies between 1 January 2015 and 30 September 2020 (N = 1 778 383). Definitions for untreated and treated HCV infection differed between the main model and sensitivity analysis models. Exact definitions used for each model are provided in the “Methods” section.Abbreviations: aHR, adjusted hazard ratio; CI, confidence interval; HCV, hepatitis C virus; IPW, inverse-probability weighting.

Adjusted for sex, municipality, and imprisonment. Models used age as the time scale and controlled the birth cohort using stratification.

Table 3.

Multivariable Models Assessing the Association of Untreated and Treated Hepatitis C With Active Tuberculosis

HCV CategoryaHR (95% CI)a
Main Model Without IPWMain Model With IPWSensitivity Analysis 1Sensitivity Analysis 2Sensitivity Analysis 3
Untreated HCV infection2.9 (2.4, 3.4)2.9 (2.4, 3.4)2.9 (2.5, 3.4)2.9 (2.4, 3.4)3.0 (2.5, 3.6)
Treated HCV infection1.7 (1.4, 2.0)1.6 (1.4, 2.0)1.7 (1.4, 2.1)1.6 (1.4, 2.0)1.5 (1.2, 1.8)
Never infected with HCV11111
HCV CategoryaHR (95% CI)a
Main Model Without IPWMain Model With IPWSensitivity Analysis 1Sensitivity Analysis 2Sensitivity Analysis 3
Untreated HCV infection2.9 (2.4, 3.4)2.9 (2.4, 3.4)2.9 (2.5, 3.4)2.9 (2.4, 3.4)3.0 (2.5, 3.6)
Treated HCV infection1.7 (1.4, 2.0)1.6 (1.4, 2.0)1.7 (1.4, 2.1)1.6 (1.4, 2.0)1.5 (1.2, 1.8)
Never infected with HCV11111

Adults tested for HCV antibodies between 1 January 2015 and 30 September 2020 (N = 1 778 383). Definitions for untreated and treated HCV infection differed between the main model and sensitivity analysis models. Exact definitions used for each model are provided in the “Methods” section.Abbreviations: aHR, adjusted hazard ratio; CI, confidence interval; HCV, hepatitis C virus; IPW, inverse-probability weighting.

Adjusted for sex, municipality, and imprisonment. Models used age as the time scale and controlled the birth cohort using stratification.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close